Scientists at MIT's Picower Institute developed a promising Alzheimer’s drug candidate, A11. Tested on three mouse strains, A11 showed reduced inflammation, decreased amyloid, and enhanced cognitive performance.
In a pivotal breakthrough, researchers from the University of Kentucky have revealed that ponesimod, an FDA-approved drug for multiple sclerosis (MS), displays significant potential as a treatment for Alzheimer’s disease.
In a significant leap forward in Alzheimer's disease (AD) research, scientists from Massachusetts General Hospital (MGH) have developed a groundbreaking 3D cellular model.
Alzheimer’s disease is a type of dementia that causes memory, thinking and behavior problems. It is the most common reasons of dementia.